• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Mucopolysaccharidoses

Mucopolysaccharidoses - 19 Studies Found

Completed : Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis
: Mucopolysaccharidosis
: 2010-11-08
:
  • Drug: Conditioning regimen

Completed : Natural History Studies of Mucopolysaccharidosis III
:
  • Mucopolysaccharidosis Type IIIA
  • Mucopolys
    : 2013-11-26
    :
    • Procedure: Lumbar puncture
    • Device: Magneti

Completed : A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
: Mucopolysaccharidosis II
: 2017-04-10
: Drug: JR-141 IV infusion (lyophilized powder), 0.01-2.0 mg/kg/week
Completed : Study of rhASB in Patients With Mucopolysaccharidosis VI
: Mucopolysaccharidosis VI
: 2005-02-24
:
  • Drug: N-acetylgalactosamine 4-sulfatase

Terminated : Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
: Mucopolysaccharidosis Type IVA
: 2012-11-21
Completed : Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
:
  • Mucopolysaccharidosis IV A
  • Mucopolysaccha
    : 2012-10-12
    : Other: Enzyme testing Leukocyte activity measurement of Arylsulfatase B and N acetyl galactosamine 6 sul
Completed : An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With MPS 7
: Mucopolysaccharidosis Type 7
: 2013-05-08
: Drug: UX003
Completed : Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)
: Mucopolysaccharidosis II
: 1999-10-18
: Genetic: lymphocyte gene therapy
Completed : Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
:
  • Mucopolysaccharidosis Type I
  • Mucopolysacc
    : 2015-05-05
    :
    • Drug: Adalimumab Subjects will

Completed : A Treatment Study of Mucopolysaccharidosis Type IIIB
:
  • MPS III B
  • Mucopolysaccharidosis Type IIIB

: 2016-02-27
: Drug: BMN 250 Chimeric fusion of recombinant human alpha-N-acetylglucosaminidase and truncated human ins
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.